Pharmaceutical Manufacturing Market Size, Share & Trends Report

Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Route of Administration, By Molecule Type, By Drug Development Type, By Sales Channel, By Age Group, By Formulation, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68039-014-2
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the pharmaceutical manufacturing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for pharmaceutical manufacturing market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of pharmaceutical manufacturing market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Pharmaceutical Manufacturing Market Categorization:

The pharmaceutical manufacturing market was categorized into eight segments, namely molecule type (Biologics & Biosimilars, Conventional Drugs), drug development type (In-house, Outsource), formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders), routes of administration (Oral, Topical, Parenteral, Inhalations), therapy area (Cardiovascular Diseases, Pain, Diabetes, Cancer, Respiratory Diseases), prescription (Prescription Medicines, Over-the-counter Medicines), age group (Children & Adolescents, Adults, Geriatric), sales channel (Retail, Non-retail), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The pharmaceutical manufacturing market was segmented into molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The pharmaceutical manufacturing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait .

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Pharmaceutical manufacturing market companies & financials:

The pharmaceutical manufacturing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • AstraZeneca, The company was established in 1999, and its headquarters is located in the UK. The company employs more than 83,500 personnel. AstraZeneca is a prominent global biopharmaceutical company that researches, develops, and commercializes a wide range of innovative medicines and therapies across various therapeutic areas. Operating within the healthcare sector, AstraZeneca is committed to advancing medical science and improving patient outcomes by addressing unmet medical needs and delivering impactful healthcare solutions.

  • Roche Ltd. , Roche Ltd is a Swiss company which employs around 103,613 people globally. F. Hoffmann-La Roche Ltd. develops and manufactures diagnostic & pharmaceutical products. It has 26 manufacturing sites globally with two business segments: pharmaceuticals and diagnostics. The pharmaceutical segment manufactures drugs for infectious diseases, cardiovascular, respiratory, & metabolic disorders, cancer, and central nervous system & autoimmune diseases. Roche Diagnostics is involved in various fields, from patient self-monitoring to clinical laboratory systems. Roche Professional Diagnostics (RPD) is the company’s largest business segment and provides solutions, tests, and instrument systems to enable reliable & cost-effective delivery of results. Ventana Medical Systems, a member of Roche Group, is involved in developing assays & kits for in situ hybridization. It operates in several regions, including North America, South America, Europe, Africa, Asia, and Oceania.

  • Thermo Fisher Scientific, Inc. , Thermo Fisher Scientific, Inc. is a publicly held biotechnology company established after the collaboration of Thermo Electron and Fisher Scientific. In 2013, in a competitive bidding with Hoffmann-La Roche, it acquired Life Technologies Corporation. Thermo Fisher provides life science, industrial & applied science, and clinical diagnostics products. The company has operations in over 50 countries. It offers products through the following brands: Thermo Scientific, Invitrogen, Fisher Scientific, Applied Biosystems, and Unity Lab Services. The company acquired Life Technologies Corp. in April 2013 and Patheon in August 2017. Patheon was established as Custom Pharmaceuticals Ltd. and changed its name in 1993. The company provides services to biotechnology and biopharmaceutical companies. It has offices across Australia, Europe, Asia, and North America. It offers solutions & services for biologics, supply chain management, product development, small molecules, and commercial product supply.

  • WuXi AppTec , WuXi AppTec offers services for the discovery and production of biologics. Its service portfolio includes solutions for discovery, development, testing, fill & finish, antibody-drug conjugates production, and technologies & platforms for biologics production. It operates in three locations in China: Wuxi, Shanghai, and Suzhou. All facilities comply with cGMP regulations. The company was established in 2000, and it is headquartered in China.

  • Samsung Biologics , Samsung Biologics provides tools and solutions for the biopharmaceutical industry. In addition, it is involved in developing and marketing bio-healthcare products. The company’s business portfolio includes process development, cGMP manufacturing, aseptic fill & finish, quality & compliance, and facilities, such as cell culture, purification, quality control, MSAT laboratory, & CCR. The total capacity of mammalian cell culture bioreactors of this company is 182,000 L.

  • FUJIFILM , FUJIFILM Holdings Corporation offers solutions for developing biopharmaceuticals. The company helps its customers in the development of biologics and vaccines. It has three manufacturing facilities in North Carolina & Texas in the U.S. and Billingham in the UK. The company’s affiliates include the UK Bioindustry Association, BioHouston, Chamber of Commerce Bryan/College Station, the Research Triangle Park, Bionow, Engineering Conference International Organization, European Society of Animal Cell Technology, the NC Biosciences Organization, ISPE Carolina South Atlantic Chapter, BioPharma Operations Group, North East Process Industry Cluster (North East Chamber of Commerce), and Morrisville Chamber of Commerce.

  • Lonza , An old Swiss company established in 1897. Lonza is a worldwide supplier of biopharmaceuticals. The company offers a variety of product ranges in bioresearch, consumer care, pharmaceutical & biotechnology, agro ingredients, industrial solutions, water treatment, and wood protection. The company operates via the following segments: pharmaceutical & biotechnology and specialty ingredients. In March 2009, the company joined the United Nations Global Compact as a strategic initiative to enhance its business. The company has worldwide operations across North America, Europe, Asia, France, and the UK, among others.

  • Catalent, Inc. , Catalent, Inc. serves various pharmaceutical companies through its innovative manufacturing services. The company operates in over 100 markets and offers services & support for over 40% of drug approvals, with over 30 locations globally for packaging. Its services include manufacturing and packing various injectable, oral, and respiratory dosage forms. It develops and delivers more than 70 billion doses, ranging from over 7,000 products. It has worldwide operations across Asia Pacific, Europe, Latin America, and North America.

  • Jubilant Pharmova Limited , Jubilant Pharmova Limited is a global pharmaceutical and life sciences company focused on developing and manufacturing APIs, allergy therapy products, solid dosage formulations, radiopharmaceuticals, fine ingredients, advanced intermediates, life science chemicals, & nutritional products. It also provides contract manufacturing services for drug discovery solutions and sterile injectables. The company serves globally in over 100 countries, directly in India, North America, Europe, and China. It has collaborations with 25 pharmaceutical and agrochemical companies worldwide.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Pharmaceutical Manufacturing Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Pharmaceutical Manufacturing Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon